Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Kidney & Renal Pelvis (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank ascending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 4.8 (4.8, 4.9) N/A 18,746 28.3
District of Columbia 6 3.1 (2.5, 3.7) 50 (47, 50) 21 26.9
Colorado 6 3.9 (3.7, 4.2) 49 (42, 50) 247 27.6
Virginia 6 3.9 (3.8, 4.1) 48 (43, 50) 395 25.4
Maryland 6 4.1 (3.9, 4.3) 47 (40, 49) 291 25.5
Hawaii 3 4.1 (3.7, 4.6) 46 (27, 50) 76 31.0
Florida 6 4.2 (4.0, 4.3) 45 (40, 48) 1,223 28.2
Utah 3 4.2 (3.9, 4.6) 44 (28, 49) 116 28.3
Oregon 6 4.3 (4.0, 4.5) 43 (31, 49) 225 27.5
Arizona 6 4.3 (4.1, 4.5) 42 (34, 48) 372 27.0
Massachusetts 3 4.4 (4.2, 4.6) 41 (28, 46) 375 28.5
Delaware 6 4.4 (3.9, 5.0) 40 (18, 49) 56 26.0
California 3 4.5 (4.4, 4.6) 39 (31, 42) 1,958 29.8
Alabama 6 4.5 (4.3, 4.8) 38 (24, 45) 280 25.0
Michigan 6 4.6 (4.4, 4.8) 37 (24, 42) 587 28.8
New Hampshire 6 4.6 (4.2, 5.1) 36 (15, 48) 85 28.7
Washington 5 4.6 (4.4, 4.8) 35 (23, 43) 402 29.8
New York 3 4.6 (4.5, 4.7) 34 (25, 40) 1,109 27.2
South Carolina 6 4.6 (4.4, 4.9) 33 (22, 43) 299 26.4
New Jersey 3 4.7 (4.5, 4.9) 32 (22, 41) 513 28.2
Pennsylvania 6 4.7 (4.6, 4.9) 31 (23, 39) 797 27.7
North Dakota 6 4.7 (4.1, 5.4) 30 (5, 49) 42 27.2
North Carolina 6 4.7 (4.5, 4.9) 29 (22, 40) 593 26.8
Connecticut 3 4.8 (4.5, 5.1) 28 (18, 41) 220 29.7
Vermont 6 4.8 (4.2, 5.6) 27 (4, 49) 42 31.4
South Dakota 6 4.9 (4.3, 5.5) 26 (5, 48) 53 29.9
Idaho 3 4.9 (4.4, 5.3) 25 (8, 44) 97 28.1
Wyoming 6 4.9 (4.2, 5.7) 24 (2, 49) 35 33.3
Montana 6 5.0 (4.4, 5.6) 23 (4, 44) 69 29.6
Kansas 6 5.1 (4.7, 5.4) 22 (7, 35) 176 26.7
Maine 6 5.1 (4.6, 5.6) 21 (4, 40) 102 30.7
Tennessee 6 5.1 (4.9, 5.4) 20 (11, 28) 425 26.1
Georgia 3 5.2 (5.0, 5.4) 19 (10, 26) 599 29.9
Rhode Island 6 5.2 (4.7, 5.8) 18 (2, 40) 70 31.5
Illinois 3 5.3 (5.1, 5.5) 17 (8, 24) 805 29.4
Ohio 6 5.3 (5.1, 5.5) 16 (7, 24) 785 30.6
New Mexico 3 5.4 (5.0, 5.8) 15 (3, 30) 139 34.9
Nebraska 6 5.4 (5.0, 5.8) 14 (2, 29) 123 30.2
Minnesota 6 5.4 (5.1, 5.7) 13 (4, 24) 361 30.9
Alaska 6 5.4 (4.6, 6.3) 12 (1, 43) 40 29.9
Texas 3 5.5 (5.4, 5.6) 11 (5, 18) 1,581 27.8
Wisconsin 6 5.5 (5.3, 5.8) 10 (3, 22) 409 29.8
Indiana 6 5.5 (5.3, 5.8) 9 (3, 21) 434 29.2
Arkansas 6 5.5 (5.2, 5.9) 8 (2, 23) 206 26.0
Missouri 6 5.5 (5.3, 5.8) 7 (3, 21) 424 29.3
Mississippi 6 5.7 (5.3, 6.0) 6 (1, 21) 203 25.6
Oklahoma 6 5.7 (5.4, 6.0) 5 (1, 19) 267 28.0
West Virginia 6 5.8 (5.4, 6.3) 4 (1, 21) 147 28.6
Kentucky 3 5.9 (5.6, 6.2) 3 (1, 12) 324 28.4
Iowa 3 6.1 (5.8, 6.5) 2 (1, 9) 245 31.9
Louisiana 3 6.2 (5.9, 6.5) 1 (1, 6) 342 28.1
Nevada 6
data not available
N/A
data not available
data not available
Puerto Rico 6 2.1 (1.9, 2.4) N/A 87 23.5
Notes:
Created by statecancerprofiles.cancer.gov on 12/08/2022 10:08 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Nevada, Puerto Rico

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top